• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Rocket Pharmaceuticals Inc (NQ: RCKT )

    18.37 -0.23 (-1.24%)
    Streaming Delayed Price Updated: 1:15 PM EDT, Aug 16, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Rocket Pharmaceuticals Inc

    < Previous 1 2 3 4 Next >
    RCKT Stock Earnings: Rocket Pharmaceuticals Misses EPS for Q2 2024
    RCKT stock results show that Rocket Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides
    Rocket Pharmaceuticals shares fell after the FDA issued a Complete Response Letter for Kresladi, a gene therapy for severe leukocyte adhesion deficiency-I. The FDA requested additional CMC... 
    Via Benzinga
    Exposures Product Safety
    Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
    These biotech stocks, lacking in profitability but seeding huge potential, should be on your watchlist. 
    Via Talk Markets
    RCKT Stock Earnings: Rocket Pharmaceuticals Beats EPS for Q1 2024
    RCKT stock results show that Rocket Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    7 Speculative Stocks to Double Your Money THIS Year
    Although terribly risky, these stocks to double your money could be enticing if you have some pocket change lying around. 
    Via InvestorPlace
    Analyst Ratings for Rocket Pharmaceuticals
    Via Benzinga
    Analyst Expectations for Rocket Pharmaceuticals's Future
    Via Benzinga
    Merit Medical Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 40 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Rocket Pharmaceuticals Stock Sees Improved Price Strength
    On Thursday, Rocket Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 68 to 78 
    Via Investor's Business Daily
    Rocket Pharmaceuticals Stock Sees RS Rating Pops Higher
    A Relative Strength Rating upgrade for Rocket Pharmaceuticals shows improving technical performance. Will it continue? 
    Via Investor's Business Daily
    Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals
    Rocket could launch its medicines sooner, but Intellia is aiming for larger markets. 
    Via The Motley Fool
    Rocket Pharmaceuticals Stock Is Blasting Off, but Here's Why You Should Tread Carefully
    Its near-term risks are subtle but bigger than their flying stock price might indicate. 
    Via The Motley Fool
    What 5 Analyst Ratings Have To Say About Rocket Pharmaceuticals
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Investors are on the hunt for undervalued, under followed and emerging stocks. Retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming. 
    Via Benzinga
    Dow Turns Lower; KULR Technology Group Shares Plummet
    U.S. stocks traded mixed toward the end of trading, with the Dow Jones falling 100 points on Wednesday. The Dow traded down 0.29% to 34,545.66 while the NASDAQ rose 0.22% to 13,803.43. The S&P 500,... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Rocket Pharmaceuticals (RCKT) Stock Up 35% Today?
    With Rocket Pharmaceuticals reaching a Phase II agreement with the FDA, RCKT stock soared, though some concerns linger. 
    Via InvestorPlace
    Exposures Product Safety
    Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Dow Gains 50 Points; US Crude Oil Inventories Rise
    U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 50 points on Wednesday. The Dow traded up 0.16% to 34,701.06 while the NASDAQ rose 0.44% to 13,834.85. The S&P 500,... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Shares of Rocket Pharmaceuticals Are Taking Off on Wednesday
    The late-stage pharmaceutical company said it had reached an agreement with the Food and Drug Administration regarding a phase 2 trial for a Danon disease therapy. 
    Via The Motley Fool
    What's Going On With Gene Therapy-Focused Rocket Pharmaceuticals Stock Today?
    On Tuesday, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501  
    Via Benzinga
    Exposures Product Safety
    Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For Wednesday
    Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. Rocket Pharmaceuticals shares rose 24.3% to $19.00 in... 
    Via Benzinga
    Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
    Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800... 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    3 Small-Cap Stocks You Can’t Ignore Now
    Finding promising small-cap stocks can be like a winning lottery ticket, providing years of steady and increasing gains to investors. 
    Via InvestorPlace
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.